📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli. (2021)

First Author: Samaras JJ

Attributed to: The Future Vaccine Manufacturing Research Hub (Vax-Hub) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12934-021-01588-1

PubMed Identifier: 34030723

Publication URI: http://europepmc.org/abstract/MED/34030723

Type: Journal Article/Review

Volume: 20

Parent Publication: Microbial cell factories

Issue: 1

ISSN: 1475-2859